Study identifies factors linked with better medication response for treatment of juvenile arthritis

Among patients with juvenile idiopathic arthritis who initiated treatment with the drug etanercept, one-third achieved an excellent response, and this response was associated with low measures of disability at study entry, younger age at the onset of JIA, and fewer disease-modifying antirheumatic drugs used before initiating etanercept, according to a new study.

Read the whole article on Science Daily

More from Science Daily